Form 4: Ralph Alvarez Acquires Eli Lilly Shares Under Directors' Deferral Plan

Director Ralph Alvarez acquired 13.708 shares of Eli Lilly common stock through the Lilly Directors' Deferral Plan, deferring cash compensation into stock units.

Summary

• Ralph Alvarez, a director of Eli Lilly & Co, acquired 13.708 shares of common stock on February 18, 2025.
• The acquisition was made under the Lilly Directors' Deferral Plan.
• The shares were acquired in lieu of cash compensation as stock units at a price of $857.2.
• Following the transaction, Alvarez beneficially owns 54,719.032 shares of Eli Lilly common stock directly.
• The acquired shares will be settled in shares of common stock following Alvarez's separation from service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction related to director compensation, indicating confidence from a company insider.

Positives

• Director's participation in the deferral plan demonstrates confidence in the company's future.
• Increased insider ownership can be viewed positively by investors.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This filing reflects routine insider transactions related to director compensation plans, which are common in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Director deferral plans are a common practice among large publicly traded companies, including pharmaceutical firms like Pfizer (PFE) and Johnson & Johnson (JNJ).
• These plans typically allow directors to defer cash compensation into stock units, aligning their interests with shareholders.
• The specific terms of deferral plans can vary, but the general structure is similar across many companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director's interests with theirs.
• The transaction has no impact on employees, customers, suppliers or creditors.

Key Dates